Harsukh Gevariya

发表

Computational analysis of the structural mechanism of inhibition of chemokine receptor CXCR4 by small molecule antagonists

J. An, Ziwei Huang, Maocai Yan, 2011, Experimental biology and medicine.

Effect of Ack1 tyrosine kinase inhibitor on ligand‐independent androgen receptor activity

D. Coppola, K. Mahajan, H. Lawrence, 2010, The Prostate.

An improved general method for palladium catalyzed alkenylations and alkynylations of aryl halides under microwave conditions

M. Botta, Harsukh Gevariya, Andrea Togninelli, 2007 .

Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants.

G. Maga, M. Botta, J. Esté, 2007, Journal of medicinal chemistry.

SYNTHESIS OF SOME NEW UNSYMMETRICAL 1,4-DIHYDROPYRIDINE DERIVATIVES AS POTENT ANTITUBERCULAR AGENTS

Anamik Shah, Harsukh Gevariya, V. Vora, 2001 .

Development of o-chlorophenyl substituted pyrimidines as exceptionally potent aurora kinase inhibitors.

Huan Yang, J. Cheng, S. Sebti, 2012, Journal of medicinal chemistry.

Dual Aurora A and JAK2 kinase blockade effectively suppresses malignant transformation

Huan Yang, U. Rix, S. Sebti, 2014, Oncotarget.

Development of novel ACK1/TNK2 inhibitors using a fragment-based approach.

K. Mahajan, H. Lawrence, N. Mahajan, 2015, Journal of medicinal chemistry.